Abiomed
Abiomed is a medical devices and Healthcare company. It's products are designed to enable the heart to rest by improving blood flow and performing the pumping of the heart. The company efforts on developing ground breaking technologies designed to improve the patient outcomes focused on native heart recovery. The headquarters is in USA.
Johnson & Johnson acquired Abiomed for 16.6 billion USD and acquisition process was completed in Dec-2022.
As of 2022, Abiomed had 2,003 employees.